title: Role of Devices in Insulin Delivery.
authors.affiliation: 1 Division of Endocrinology, UT Southwestern Medical Center , Dallas, Texas.|2 Global Diabetes Program, Parkland Health & Hospital System , Dallas, Texas.
authors.forename: Luigi F
authors.initials: LF
authors.lastname: Meneghini
authors.affiliation: 2 Global Diabetes Program, Parkland Health & Hospital System , Dallas, Texas.
authors.forename: Jacqueline Nicole
authors.initials: JN
authors.lastname: McNulty
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D048909:Diabetes Complications / Q000191:economics / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000191:economics / Q000639:trends; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D007277:Injections, Jet; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D007332:Insulin Infusion Systems / Q000009:adverse effects / Q000191:economics / Q000639:trends; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use
chemical_list: D059451:Biosimilar Pharmaceuticals; D007004:Hypoglycemic Agents; D007328:Insulin; D011994:Recombinant Proteins